Description
Here is a short introduction to PPVC’s CREOPM™
Framework: A unique and holistic process
and methodology to maximize portfolio value
Dr. Richard Bayney, President & Founder, Project Portfolio
Value Creation, gives a 10 minute sampling of the Portfolio Management Master
Class.
Back by popular demand, the class is being held on May 8, 2017, in Boston, MA and October 2, 2017, in Ft. Worth, TX.
Learn to shape the strategic and financial goals of your company
by using compelling and actionable portfolio analysis to influence corporate
decision-makers.
- Align corporate goals with your investment strategy
- Use CREOPM™ (Categorize – Risk Analysis – Evaluate – Optimize – Prioritize – Manage) to maximize portfolio value
- Optimally locate constrained R&D resources
- Understand value lost by pursuing inefficient portfolios
- Make smart trade-offs between business sectors
- Create sustainable portfolio success
For more details and registration information please visit IRI’s Website
Contributors
-
Dr. Richard Bayney, President & Founder, Project Portfolio Value Creation
Dr. Richard Bayney is President & Founder of Project & Portfolio Value Creation, a consulting boutique providing training and education in project, program, portfolio, resource, and risk management as well as client services in strategic, business, and portfolio planning. He is an adjunct faculty member at the University of Pennsylvania.
Dr. Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Bayer Corp. and AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development. He obtained his MSc and PhD from University of London, MBA from Columbia University, and PMP from the Project Management Institute. In his last corporate position, Dr. Bayney was Head of Decision Analysis & Portfolio Management at Johnson & Johnson Pharmaceutical Research & Development.